Novel Psilocin Derivatives as Serotonergic Psychedelic Agents for Treating CNS Disorders.
Provided herein are novel psilocin derivatives as serotonergic psychedelic agents, pharmaceutical compositions, use of such compounds in treating central nervous system (CNS) disorders, and processes for preparing such compounds.